EXEGI PHARMA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 29 Jun 2024)
What this means for you
Registered since 19 Dec 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86419162
- Registration number
- 5360299
- Mark type
- Stylized text
- Filed
- 09 Oct 2014
- Published for opposition
- 29 Sept 2015
- Registered
- 19 Dec 2017
- Attorney of record
- John W. McGlynn
Goods and services
- Class 005 — Pharmaceuticals: Food supplements; Food supplements for treating digestive disorders; Health food supplements; Nutritional supplements, namely, probiotic compositions; Dietary and nutritional supplements; Pharmaceutical preparations for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver diseases; Drugs, Biologic drugs and live biotherapeutics for the treatment of inflammatory bowel diseases, ulcerative colitis, irritable bowel syndrome, pouchitis, liver disease; Medical Food, namely, dietetic foods in the nature of powder specially adapted for medical use; Probiotic supplements
Owner
- EXEGI PHARMA, LLC, Rockville, MD, US
- EXEGI PHARMA, LLC, Gaithersburg, MD, US
- EXEGI PHARMA, LLC, Gaithersburg, MD, US
Prosecution history
- 29 Jun 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 29 Jun 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 29 Jun 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 19 Dec 2023 — TEAS SECTION 8 & 15 RECEIVED
- 19 Dec 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Dec 2017 — REGISTERED-PRINCIPAL REGISTER
- 14 Nov 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Nov 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 10 Nov 2017 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Nov 2017 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Nov 2017 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Jun 2017 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 06 Jun 2017 — NON-FINAL ACTION E-MAILED
- 06 Jun 2017 — SU - NON-FINAL ACTION - WRITTEN
- 05 Jun 2017 — STATEMENT OF USE PROCESSING COMPLETE